1.
|
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 50 and under
Sponsor: Other
Protocol IDs: MSGCC-9739, NCI-V98-1433, NCT00003398
|
|
2.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MSGCC-9721, NCI-V98-1438
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: SMD/ATG-CSA/2002, NCT00488436
|
|
4.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 50
Sponsor: Other
Protocol IDs: CHIMERIC-HM01, WSU-10-02-99-M01-FB, NCT00004255
|
|
5.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 1 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-9911052, ABX-CB-9906, NCI-G01-1916, NCT00012077
|
|
6.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 35 and under
Sponsor: Other
Protocol IDs: 9504M09637, MT2000-18, NCT00176878
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: SWS-SAKK-33/99, NCT00004208
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 5 to 55 preferred
Sponsor: NCI
Protocol IDs: MSKCC-93045, NCI-H93-0293, NCT00002534
|
|
9.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 55 and below
Sponsor: NCI
Protocol IDs: FHCRC-1126.00, NCI-V97-1211
|
|
10.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 17 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP-0134-004, NCI-V97-1219
|
|
11.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI
Protocol IDs: FHCRC-1127.00, NCI-G97-1230
|
|
12.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: NHLBI
Protocol IDs: NHLBI-98-H-0006, NCT00003552
|
|
13.
|
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI
Protocol IDs: FHCRC-1723.00, NCT00054340
|
|
14.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL3X, EU-20554, MEDAC-FLUD.10/CLL, NCT00281983
|
|
15.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Children
Sponsor: NCI
Protocol IDs: UCSF-01152, UCSF-H411-17802-06, NCT00305708
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 40 and under
Sponsor: Other
Protocol IDs: FHCRC-710.01, NCI-V94-0388
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI
Protocol IDs: MSKCC-95084, NCI-V96-0809, NCT00002718
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 17 to 60
Sponsor: Other
Protocol IDs: TUHSC-2803, NCI-V96-0950, NCT00002809
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 0 to 54
Sponsor: NCI
Protocol IDs: MDA-DM-93031, NCI-G96-0993
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 5 to 50
Sponsor: NCI
Protocol IDs: RPCI-DS-97-26, NCI-G98-1406, NCT00003270
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Under 55
Sponsor: NCI
Protocol IDs: CASE-CWRU-4Y97, NCI-G98-1429, NCT00003335, CASE-4Y97
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 55 and under
Sponsor: NCI
Protocol IDs: CASE-CWRU-5Y97, NCI-G98-1431, NCT00003336, CASE-5Y97
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MSGCC-9805, NCI-V98-1430, NCT00003396
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-78-C-35, NCI-MB-100, NCI-VA-MOB-773
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Under 55
Sponsor: NCI
Protocol IDs: RPCI-RP-9801, DUMC-344-98-2R4, NCI-G98-1485, NCT00003661
|
